Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01904903
Title Cardiac Safety Study in Patients With HER2+ Breast Cancer (SAFE-HEaRt)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington Hospital Center
Indications

Her2-receptor positive breast cancer

Therapies

Pertuzumab

Ado-trastuzumab emtansine

Trastuzumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.